Stock listing

Hanover:6IV Inventiva SA Aktie

German listing (Hanover) of Inventiva SA · home listing Euronext:IVA

Follow Inventiva SA into a list and get an email when it puts out news.

Home listing price · EURONEXT:IVA

€2.74 EUR -0.10 (-3.5%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:IVA

Since Jul 6, 2026 -19.9% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
€2.71 – €2.94 EUROct 16, 2026
Volume
630,638 sharesOct 16, 2026
Market value
€646.1M EURAt the close on Oct 16, 2026 · price × 236.2M shares outstanding
Inventiva SA logo
Ticker
Hanover:6IV
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Hanover
Currency
EUR

What changed lately

Calls

Replays

  • Inventiva (Euronext:IVA) Q1 2026 Earnings Call

    Tue, Apr 28, 2026 · 8:00 AM ET

    Watch Transcript

  • Inventiva (Euronext:IVA) Q4 2025 Earnings Call

    Tue, Mar 31, 2026 · 8:00 AM ET

    Watch Transcript

  • Inventiva (Euronext:IVA) Q4 2023 Earnings Call

    Thu, Mar 28, 2024 · 8:00 AM ET

    Watch Transcript

Latest news

Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026

Oct 6, 2026

Inventiva publie ses résultats financiers non audités du premier semestre 2026 et fait le point sur ses activités

Sep 28, 2026

Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update

Sep 28, 2026

Inventiva to Present Multiple Abstracts at Paris MASH 2026

Sep 8, 2026

Inventiva présentera plusieurs abstracts lors du Congrès Paris MASH 2026

Sep 7, 2026

Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH

Sep 2, 2026

Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH

Sep 1, 2026

Inventiva Appoints Chris Benecchi as Chief Operating Officer

Aug 31, 2026

Inventiva nomme Chris Benecchi au poste de Chief Operating Officer

Aug 30, 2026

Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹

Jul 30, 2026

All Inventiva SA news

Decks

Inventiva SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
38 in the last 12 months · 56 in all · newest Oct 6, 2026 · oldest 2025
Calls
5 calls with a replay · 5 with a transcript · latest Apr 28, 2026
Decks
12 decks · latest October 2026

Where Inventiva SA is listed

ListingExchangeCountryCurrency
Euronext:IVA · Home listingEuronextFranceEUR
NASDAQ:IVANASDAQUnited StatesUSD
gettex:6IVgettexGermanyEUR
LSE:0RNKLSEUnited KingdomEUR
LS Exchange:A2DLV9LS ExchangeGermanyEUR
Lang & Schwarz:A2DLV9Lang & SchwarzGermanyEUR
Tradegate:6IVTradegateGermanyEUR
OTC:IVEVFOTCUnited StatesUSD
Xetra:6IVXetraGermanyEUR
BOATS:IVABOATSUnited StatesUSD
Aquis:IVAPAquisUnited KingdomEUR
Hamburg:6IVHamburgGermanyEUR
Dusseldorf:6IVDusseldorfGermanyEUR
Frankfurt:6IVFrankfurtGermanyEUR
Munich:6IVMunichGermanyEUR
Aquis:IVAPAquisUnited KingdomEUR
Frankfurt:6IVAFrankfurtGermanyEUR
gettex:6IVAgettexGermanyEUR
Lang & Schwarz:A2P796Lang & SchwarzGermanyEUR
LS Exchange:A2P796LS ExchangeGermanyEUR
Munich:6IVAMunichGermanyEUR
Stuttgart:6IVStuttgartGermanyEUR
Stuttgart:6IVAStuttgartGermanyEUR
Hanover:6IV · This pageHanoverGermanyEUR

Log in to ask 6ix AI your own questions about Inventiva SA.